Literature DB >> 23248217

Primary cardiac lymphoma mimicking infiltrative cardiomyopathy.

Ga Yeon Lee1, Won Seog Kim, Young-Hyeh Ko, Jin-Oh Choi, Eun-Seok Jeon.   

Abstract

Primary cardiac lymphoma is a rare malignancy which has been described as thickened myocardium due to the infiltration of atypical lymphocytes and accompanying intracardiac masses. Here, we report a case of a primary cardiac lymphoma without demonstrable intracardiac masses, mimicking infiltrative cardiomyopathy. A 40-year-old male presented with exertional dyspnoea and was diagnosed as having restrictive cardiomyopathy with severely decreased LV systolic function. Endomyocardial biopsy was performed and the diagnosis of primary cardiac lymphoma was confirmed. After appropriate chemotherapy, he recovered his systolic function fully.

Entities:  

Mesh:

Year:  2012        PMID: 23248217     DOI: 10.1093/eurjhf/hfs193

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  4 in total

1.  Diastolic heart failure associated with hemangiosarcoma infiltrating left ventricular walls in a dog.

Authors:  Tatsuyuki Osuga; Kensuke Nakamura; Tomoya Morita; Yumiko Kagawa; Hiroshi Ohta; Mitsuyoshi Takiguchi
Journal:  Can Vet J       Date:  2017-11       Impact factor: 1.008

Review 2.  Primary cardiac lymphoma: two cases and a review of literature.

Authors:  Karolis Jonavicius; Kestutis Salcius; Raimundas Meskauskas; Nomeda Valeviciene; Virgilijus Tarutis; Vytautas Sirvydis
Journal:  J Cardiothorac Surg       Date:  2015-10-30       Impact factor: 1.637

3.  Diffuse infiltrative primary cardiac lymphoma with delayed extracardiac involvement.

Authors:  Yong Jeoung; Se Ryeon Lee; Ho Kim; Ji Won Kim; Jae Joong Lee; Sang Yoon Chung
Journal:  Chonnam Med J       Date:  2014-04-22

4.  Cardiac Infiltration as the First Manifestation of Acute Lymphoblastic Leukemia: A Systematic Review.

Authors:  Zhi Luo; Jun Cheng; Yanggan Wang
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.